| Vanica Monae Guignard, | |
|
18101 Prince Philip Dr, Olney, MD 20832-1514 | |
| (305) 905-1988 | |
| Not Available |
| Full Name | Vanica Monae Guignard |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 18101 Prince Philip Dr, Olney, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417511957 | NPI | - | NPPES |
| Entity Name | Medstar Urgent Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902175870 PECOS PAC ID: 9335303155 Enrollment ID: O20120607000236 |
News Archive
Plexxikon Inc. today announced encouraging clinical data from a Phase 1 extension study of PLX4032 (RG7204) in metastatic melanoma patients, which expand the results announced from the initial phase of the study. PLX4032 is a novel, oral and highly selective drug that targets the BRAFV600E cancer-causing mutation that occurs in about 50 percent of melanomas and about eight percent of all solid tumors.
The National Multiple Sclerosis Society has just committed over $1 million to support a clinical trial at the University of Iowa led by Terry Wahls, MD, to compare the ability of two popular diets to treat multiple sclerosis-related fatigue, a disabling symptom that can significantly interfere with a person's ability to function at home and work.
New research published in the May issue of the Journal of the American College of Surgeons shows that dramatic disparities in breast cancer outcomes continue to exist for African-American women, regardless of the age at which they are diagnosed, extent of the cancer, type of treatment or socioeconomic status.
A new study published in the journal Nature Communications in March 2020 reports that a fifth of the malaria risk in deforestation hot spots is down to the export trade in coffee, timber, soybean, cocoa, wood products, palm oil tobacco, beef, and cotton.
One type of over-the-counter product for topical wound care is more effective than others in killing methicillin-resistant Staphylococcus aureus bacteria, or MRSA, which is potentially deadly and in recent years has moved from its historic hospital setting to a much broader public concern.
› Verified 2 days ago
| Entity Name | Whc Physician Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700154226 PECOS PAC ID: 6103093513 Enrollment ID: O20140711000014 |
News Archive
Plexxikon Inc. today announced encouraging clinical data from a Phase 1 extension study of PLX4032 (RG7204) in metastatic melanoma patients, which expand the results announced from the initial phase of the study. PLX4032 is a novel, oral and highly selective drug that targets the BRAFV600E cancer-causing mutation that occurs in about 50 percent of melanomas and about eight percent of all solid tumors.
The National Multiple Sclerosis Society has just committed over $1 million to support a clinical trial at the University of Iowa led by Terry Wahls, MD, to compare the ability of two popular diets to treat multiple sclerosis-related fatigue, a disabling symptom that can significantly interfere with a person's ability to function at home and work.
New research published in the May issue of the Journal of the American College of Surgeons shows that dramatic disparities in breast cancer outcomes continue to exist for African-American women, regardless of the age at which they are diagnosed, extent of the cancer, type of treatment or socioeconomic status.
A new study published in the journal Nature Communications in March 2020 reports that a fifth of the malaria risk in deforestation hot spots is down to the export trade in coffee, timber, soybean, cocoa, wood products, palm oil tobacco, beef, and cotton.
One type of over-the-counter product for topical wound care is more effective than others in killing methicillin-resistant Staphylococcus aureus bacteria, or MRSA, which is potentially deadly and in recent years has moved from its historic hospital setting to a much broader public concern.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vanica Monae Guignard, 6800 Georgia Ave Nw Apt 349, Washington, DC 20012-2676 Ph: (305) 905-1988 | Vanica Monae Guignard, 18101 Prince Philip Dr, Olney, MD 20832-1514 Ph: (305) 905-1988 |
News Archive
Plexxikon Inc. today announced encouraging clinical data from a Phase 1 extension study of PLX4032 (RG7204) in metastatic melanoma patients, which expand the results announced from the initial phase of the study. PLX4032 is a novel, oral and highly selective drug that targets the BRAFV600E cancer-causing mutation that occurs in about 50 percent of melanomas and about eight percent of all solid tumors.
The National Multiple Sclerosis Society has just committed over $1 million to support a clinical trial at the University of Iowa led by Terry Wahls, MD, to compare the ability of two popular diets to treat multiple sclerosis-related fatigue, a disabling symptom that can significantly interfere with a person's ability to function at home and work.
New research published in the May issue of the Journal of the American College of Surgeons shows that dramatic disparities in breast cancer outcomes continue to exist for African-American women, regardless of the age at which they are diagnosed, extent of the cancer, type of treatment or socioeconomic status.
A new study published in the journal Nature Communications in March 2020 reports that a fifth of the malaria risk in deforestation hot spots is down to the export trade in coffee, timber, soybean, cocoa, wood products, palm oil tobacco, beef, and cotton.
One type of over-the-counter product for topical wound care is more effective than others in killing methicillin-resistant Staphylococcus aureus bacteria, or MRSA, which is potentially deadly and in recent years has moved from its historic hospital setting to a much broader public concern.
› Verified 2 days ago
Jeremy H Graf, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 18101 Prince Philip Dr, Olney, MD 20832 Phone: 301-774-8900 Fax: 301-570-8574 | |
Kerri H Suissa, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 18101 Prince Philip Dr, Olney, MD 20832 Phone: 301-774-8900 Fax: 301-570-8574 | |
Michael K Kerr, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 18101 Prince Philip Dr, Montgomery General Hospital, Olney, MD 20832 Phone: 301-774-8900 Fax: 301-570-8574 | |
Ellen L Smith, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 18101 Prince Philip Dr, Olney, MD 20832 Phone: 301-774-8900 Fax: 301-570-8574 | |
Dr. Jeffrey Uribe, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 18101 Prince Philip Dr, Olney, MD 20832 Phone: 301-774-8882 | |
Robert F Larkin, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 18101 Prince Philip Drive, Montgomery General Hospital, Olney, MD 20832 Phone: 301-774-8900 Fax: 301-570-8574 |